Mental Health Software Market Insights, Share, Growth Drivers and Future Scope

The global mental health software market is growing significantly, due to high potential of subscription model. During the forecast period, the providers segment is expected to hold the largest share, among all the end user segments of the global mental health software market, due to its extensive use for maintaining patient records and management revenue cycle. However, the residential segment is expected to grow with the highest rate during the forecasted period, due to increasing use of behavioral/ mental health solution by patients in their homes for better self-care. Among the various delivery models of mental health software, the subscription model segment is expected to grow with the faster rate, as it is user friendly and cost effective. Moreover, the support services led the component segment of the market, due to recurring requirement of these services for software up-gradation and management.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/mental-health-software-market/report-sample

The unexplored market in the mental health software industry of the developing economies is creating growth opportunities for the mental health software market. Some of the major trends in the global market are growing product innovation, increasing number of collaborations and partnerships, and increasing number of mergers and acquisitions. The mental health software helps behavioral health professionals to plan treatment for patients suffering from mental problems, such as depression, addiction, stress and anxiety. The software helps user to facilitate medical bills and schedule online appointments.

Geographically, North America is expected to dominate the global market in the coming years, due to increasing government support and increasing patient base seeking behavioral services. Asia is expected to be the fastest growing region, due to increasing healthcare expenditure and increasing government initiatives and support within the region. In addition, the market in Asia is growing, due to increasing awareness about mental health software in the emerging countries, such as India and China.

Browse report at: https://www.psmarketresearch.com/market-analysis/mental-health-software-market

Some of the companies operating in the global mental health software market are Epic Systems Corporation, McKesson Corporation, Cerner Corporation, MindLinc, Allscripts,The Echo Group, Netsmart Technologies Inc., Qualifacts Systems Inc., Practice Fusion, General Electric Company, eClinicalWorks, Core Solutions Inc., Welligent Inc., and Valant Inc.

Read More

Health IT Security Market 2019 - Recent Study Including Growth Factors, Applications and Forecast till 2024

The global health IT security market is witnessing considerable growth due to stringent regulatory requirements and interconnected medical devices. Since the usage of interconnected medical device is continuously increasing, health IT security would play a major role in the safety of health information assembled and imparted from various smart devices to patients and care givers.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/health-it-security-market/report-sample

Moreover, increasing use of mobile device, due to greater adoption of bring-your-own device policy, is supporting the growth of the market. The adoption of health IT security across the globe is increasing, owing to increasing number of healthcare data breeches. The market for healthcare IT security services segment is expected to grow at the faster rate compared to healthcare IT security products market in the forecasted period, as the end users in this market would require continuous support in the form of service to protect their IT infrastructure from increased advanced cyber-attacks.

The cloud security proposes new growth avenues of health IT security, and evolution of next generation IT security solution is expected to create opportunities for the market. In addition, massive unexplored market in developing economies are creating abundant opportunities for the health IT security market to grow at a significant rate in the coming years. However, limited cyber security professionals and limited spending on IT security are the key factors hampering the growth of the global market.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=health-it-security-market

The digital health technologies help to improve communication between patients and healthcare providers to reduce medical errors for better coordinated care. These technologies also help to share information with other healthcare organizations and providers, such as medical imaging facilities, emergency facilities, laboratories, clinics, and pharmacies. Reliability, better health management and cost efficiency are major goals to be achieved in healthcare sector.

Geographically, North America has been the largest market for health IT security, owing to large number of healthcare data breeches, and stringent regulatory requirements on data privacy in the region. The U.S. contributed largest revenue to the North American as well as global health IT security market. Europe has been the second largest market for health IT security, where the market is driven by the increasing number of cyber-attacks to misuse healthcare information of an individual. Globally, the health IT security market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing awareness of IT security and increasing adoption of connected medical devices for managing increasing prevalence of chronic illness in the region.

Browse report at: https://www.psmarketresearch.com/market-analysis/health-it-security-market

The key players operating in the global market are IBM Corporation, Symantec Corporation, Trend Micro Incorporated, Oracle Corporation, EMC Corporation, SailPoint Technologies, Dell Inc., Hewlett Packard, AT&T, and Intel Corporation.

Read More

Peanut Allergy Therapeutics Analysis, Clinical Trials, Collaborations and Developments

Peanut allergy is one of the most common type of allergies caused by a legume, known as peanut. Peanut is an annual herbaceous plant that belongs to the family of legumes. Other examples of legumes that can cause the disease include lentils, peas, and soybeans. Peanut allergy can be unpredictable and life-threatening and can bring the body into shock (anaphylaxis). The study analyzed that peanut allergy therapeutics pipeline comprises approximately 19 drug candidates in different stages of development.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/peanut-allergy-therapeutics-pipeline-analysis/report-sample

According to the research findings, a majority of the drug candidates for the treatment of peanut allergy are being developed to be administered by the oral route which is convenient to take, and has been considered as non-invasive, and is often a safer route that requires no special training to be given to the patients.

It has been observed that most of the companies are developing drug candidates by using advanced technologies and the drug candidates have showed positive efficacy in the clinical as well as Pre-Clinical stage of development. For instance, BioLingus Inc. is utilizing its technology, BioLingus technology, which is a micro-encapsulation process, that delivers macro molecules such as peptides and proteins and is particularly effective for sublingual immunotherapy. With this technology, it has been observed in the Pre-Clinical models that sublingual IL-2 is found efficacious in 500th times lower amount than the investigational sublingual IL-2 therapy for the treatment of peanut allergy.

Browse report at: https://www.psmarketresearch.com/market-analysis/peanut-allergy-therapeutics-pipeline-analysis

Some of the key players involved in the development of peanut allergy therapeutics include Aimmune Therapeutics Inc., DBV Technologies S.A., and AnaptysBio Inc.

Source: P&S Intelligence

Read More

Europe Drug of Abuse Testing Market Analysis, Share, Growth Drivers and Forecast by 2023

The European DOA testing market is forecasted to reach $3.0 billion by 2023. Growing alcohol consumption, rising drug trafficking, and increasing government initiatives that aim at increasing interdiction capacities and strengthening law enforcement in the region are some notable factors supporting the demand for DOA testing products and services in the region.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/europe-doa-testing-market/report-sample

The products category held larger share, of 80.1%, in the European DOA testing market in 2017. This category is predicted to grow at a CAGR of 9.2% during the forecast period, mainly due to the increasing number of drug abuse cases, development of technologically advanced products, and increasing awareness toward DOA testing in the region.

The products in the DOA testing market in Europe are further sub-categorized into consumables and equipment. The consumables used for DOA testing are rapid test kits, assay kits and reagents, and others. Of these, rapid test kits held the largest share in the European DOA testing consumables market, and generated more than $400.0 million revenue in 2017. This can be ascribed to the increasing use of these kits at point-of-care settings for the qualitative assessment of drugs and/or their metabolites in human urine for screening, diagnostic purposes, and forensic use.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=europe-doa-testing-market

The U.K. DOA testing market is expected to observe the fastest growth, at a CAGR of 11.0% during the forecast period, mainly due to the increasing availability and consumption of illicit drugs in the country. According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), in 2017, the prevalence of cannabis use was the highest in the U.K. among all European countries, with drug consumption reported approximately 11.3% in young adults aged 16–34 years. Furthermore, the U.K. government is taking initiatives to address the healthcare challenges in the country by making investments in innovative projects for drug users to overcome drug abuse and addiction.

In November 2017, Thermo Fisher Scientific Inc. announced the launch of Thermo Scientific TruNarc handheld narcotics analyzer. This narcotic analyzer can detect Carfentanil, a fentanyl analog, which is 10,000 times more powerful than morphine.

Browse report at: https://www.psmarketresearch.com/market-analysis/europe-doa-testing-market

Siemens AG, Merck KGaA, Drägerwerk AG & Co. KGaA, bioMérieux S.A., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Abbott Laboratories, Quest Diagnostics Inc., Danaher Corporation, Bioventix Plc, Express Diagnostics Int'l Inc., Psychemedics Corporation, and Lipomed AG are other key players present in the European DOA testing market.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Read More

Next Generation Antibody Therapeutics Market Share, Growth and Future Analysis

The global next-generation antibody therapeutics market is growing due to increasing popularity of antibody-drug conjugate and increasing number of collaborations for R&D in next-generation antibody therapeutics. In addition, growing prevalence of chronic diseases and increase in research and development investments by various organizations for production of improved products further encourages the growth of global next-generation antibody therapeutics market. Furthermore, increase in healthcare expenditure and technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, which is resulting in increased demand for next-generation antibody therapeutics.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample

Governments of various countries are involved in taking initiatives for improving healthcare facilities, and making next-generation antibody therapeutics affordable. This is increasing the demand for next-generation antibody therapeutics. The increasing global gross domestic product (GDP) and growing healthcare expenditure have created a positive impact on the growth of the next-generation antibody therapeutics market. Also, in comparison to traditional antibodies, the next-generation antibody therapeutics is more effective in the treatment of various diseases, such as cancer, autoimmune disorders, and inflammatory diseases. This is attracting various pharmaceutical and biotechnology companies to increase their investment in the R&D of next-generation antibody therapeutics.

However, certain restraints such as high cost of next-generation antibody therapeutics, stringent regulatory requirements and time-consuming approval process for new drugs are hindering the market growth. North America next-generation antibody therapeutics market is expected to witness the fastest growth of CAGR 46.2% globally, during the period 2015 – 2020.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=next-generation-antibody-market

The key companies operating in the global next-generation antibody therapeutics market include Seattle Genetics Inc., F. Hoffmann-La Roche Ltd, ImmunoGen Inc., Pfizer Inc., Amgen Inc., Biogen, Kyowa Hakko Kirin Co. Ltd., Bristol-Myers Squibb Company, Xencor Inc., AstraZeneca PLC., Dyax Corp., Takeda Pharmaceuticals Company Limited and Bayer AG.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Read More

European Wound Closure Products Market Insights, Share, Growth and Demand till 2022

The European wound closure market was valued at $2.8 billion in 2015 and is expected to grow at a CAGR of 5.9% between 2016-2022, to reach $4.2 billion by 2022. European wound closure products market is growing due to increase in aging population, diabetes cases, and obesity levels. Among the European nations, the German market for wound closure products is expected to grow at a CAGR of 6.6% during the forecast period, to reach $1.1 billion by 2022.

Get a Sample Copy of This Report at: https://www.psmarketresearch.com/market-analysis/wound-closure-products-market/report-sample

The high cost of wound closure products limits the growth of the wound closure products market. High cost of wound closure products, such as adhesives and tissue sealants, haemostats, sutures and wound closure strips limits the affordability of the users. In addition, the manufacturing of these products also requires material with specific characteristic features, thus leading to higher cost. Moreover, raw materials required for manufacturing of wound closure products have specific requirements.

Companies in the wound closure products market are undergoing mergers and acquisitions to improve their market share. For instance, in August 2016, Derma Sciences Inc. completed the acquisition of privately held BioD LLC with an immediate transaction value of $21.3 million and a potential total transaction value of an estimated $77.8 million. This includes an upfront payment of cash and common stock of $21.3 million, as well as potential product regulatory milestone payments in aggregate estimated to be up to $30.0 million and earn outs based on incremental net sales growth of up to $26.5 million. BioD LLC is a biotechnology company involved in the development and commercialization of novel and biologic products. The acquisition has been made to expand Derma Sciences’ regenerative medicine and advanced wound care products portfolio.

Explore Report at: https://www.psmarketresearch.com/market-analysis/wound-closure-products-market

Some of the key companies operating in the wound closure products market include 3M Company, Medtronic plc, Smith and Nephew plc, CryoLife Inc., DeRoyal Industries Inc., Pfizer Inc., Derma Sciences Inc., Johnson and Johnson, B. Braun Melsungen AG and Baxter International Inc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Read More